ClinicalTrials.Veeva

Menu

National Cancer Institute Thai Cancer Anemia Survey

Janssen (J&J Innovative Medicine) logo

Janssen (J&J Innovative Medicine)

Status

Completed

Conditions

Anemia
Cancer

Treatments

Other: Adult Cancer Patients

Study type

Observational

Funder types

Industry

Identifiers

NCT01030159
CR012703
TCAS-NCI-ONCO-2006

Details and patient eligibility

About

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Full description

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Enrollment

300 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with cancer

Exclusion criteria

  • N/A

Trial design

300 participants in 1 patient group

001
Treatment:
Other: Adult Cancer Patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems